PharmaCyte Biotech

3 Decision Makers · 5 Verified Contacts & Email Format

📍 Laguna Hills, California, United StatesBiotechnology🗓 Est. 1996👥 Under 10 employees

About PharmaCyte Biotech

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer.

Email Format

{first_name}.{last_name}@pharmacytebiotech.com — 100.0%

sarah.smith@pharmacytebiotech.com

Leadership & Decision Makers

Contact details of 3 PharmaCyte Biotech decision makers

Kenneth Waggoner

Chief Executive Officer, President and General Counsel
  • Work email

    k*******r@pharmacytebiotech.com

Eva Maria Brandtner

Director of Diabetes Program Development

Jose Iglesias

Consulting Chief Medical Officer

Team & Specialists

Contact details of 2 PharmaCyte Biotech team members

Walter Gunzburg

CSO

Matthias Lohr

Consultant

General Emails

General company emails, e.g. customer support lines

    info@PharmaCyte.com

    General Inquiries

    info@pharmacytebiotech.com

    General Inquiries

Similar Companies like PharmaCyte Biotech

Bio-Techne

bio-techne.com
Biotechnology · Minneapolis, MN · Est. 1981 · 1001–5000 employees

HQ: Minneapolis, MN

NuVasive

nuvasive.com
Biotechnology · San Diego, CA · Est. 1997 · 1001–5000 employees

HQ: San Diego, CA

Karl Storz

karlstorz.com
Biotechnology · Tuttlingen, Baden-Wurttemberg, Germany · Est. 1945 · 1001–5000 employees

HQ: Tuttlingen, Baden-Wurttemberg, Germany

Edwards Lifesciences

edwards.com
Biotechnology · Irvine, CA · Est. 1958 · 5001–10000 employees

HQ: Irvine, CA

Integra LifeSciences

integralife.com
Biotechnology · Princeton, NJ · Est. 1989 · 5001–10000 employees

HQ: Princeton, NJ

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 14/07/2025

(917)595-2850

Laguna Hills, California, United States

Specialization: Clinical Trials,
Business Type: Public
Employees: 1-10
Rounds: Post-IPO Equity
Founded Date: 1996
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:PMCB
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: (917)595-2850
Last Investment Activity: Nov 15, 2023
Investments Activity: Nov 15, 2023 Oct 31, 2023 Jun 15, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.